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Edited by Stuart FergusonAbstract Alkaline incubation of NADH results in the forma-
tion of a very potent inhibitor of complex I (NADH:ubiquinone
oxidoreductase). Mass spectroscopy (molecular mass equal to
696) and absorption spectroscopy suggest that the inhibitor is de-
rived from attachment of two oxygen atoms to the nicotinamide
moiety of NADH. The inhibitor is competitive with respect to
NADH with a Ki of about 10
8 M. The inhibitor eﬃciently sup-
presses NADH-oxidase, NADH-artiﬁcial acceptor reductase,
and NADH-quinone reductase reactions catalyzed by submito-
chondrial particles, as well as the reactions catalyzed by either
isolated complex I or the three subunit ﬂavoprotein fragment
of complex I.
Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Complex I (NADH:ubiquinone oxidoreductase) provides
the entry point for electrons from NADH to the respiratory
chain of mitochondria and bacteria. The enzyme transfers elec-
trons from NADH to a non-covalently bound FMN cofactor
and then via a series of at least eight iron-sulfur (FeS) clusters
to ubiquinone which is the terminal electron acceptor. This 2e
transfer reaction is coupled to the translocation of 4H+ across
the mitochondrial inner membrane which contributes to the
proton motive force used by the mitochondrial ATP synthase
to generate ATP. The best characterized complex I is that from
beef heart mitochondria and its subunit composition and prop-
erties have been elegantly reviewed by John Walker [1]. The
mammalian enzyme is now known to contain 46 diﬀerent
subunits with a total molecular mass of 980 kDa [2] making
it one of the largest of the cellular machines. Treatment ofAbbreviations: SMP, submitochondrial particles; HAR, hexaamineru-
thenium (III) chloride; DCIP, 2,6-dichlorophenol-indophenol; FP,
three subunit ﬂavoprotein fragment of complex I
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such as sodium perchlorate results in solubilization of a ‘‘min-
imal’’ catalytically active fragment, the so-called FP (ﬂavopro-
tein) composed of only three subunits (51, 24, and 10 kDa) [3].
FP contains ﬂavin and two iron-sulfur clusters and catalyzes
rotenone-insensitive NADH oxidation by artiﬁcial electron
acceptors. Despite the fact that FP can not catalyze ubiqui-
none reduction it can serve as a useful model for studying
the molecular mechanism of NADH dehydrogenation at the
active site.
There are two main types of activities catalyzed by the
enzyme: NADH:ubiquinone and NADH:artiﬁcial acceptor
reductase reactions. The former includes the complete sequence
of electron transfer reactions from the NADH dehydrogenat-
ing site via the prosthetic groups of complex I to the ubiquinone
reduction site. The reaction is sensitive to speciﬁc inhibitors of
Q reduction (rotenone and piericidin) and associated with
vectorial proton translocation through the mitochondrial mem-
brane. NADH:acceptor reductase reactions are evidently
abbreviated compared to the natural electron pathway. Two
main acceptors, ferricyanide and hexaamineruthenium (III)
are usually used for measuring activity of complex I [4]. These
activities in contrast to NADH:ubiquinone reduction are insen-
sitive to rotenone and piericidin and are not linked to proton
translocation.
Despite the considerable progress recently achieved in
understanding the structure, molecular composition, and evo-
lution of complex I, knowledge of the molecular mechanism of
substrate dehydrogenation, intramolecular electron transfer,
and the coupling of electron transfer with vectorial proton
transfer still remains a matter of speculation. Little is known
about regulation of complex I in the cell. More than a decade
ago it was proposed that the mechanism of complex I regula-
tion is based on its slow and reversible transition from an
active form to a deactive form [5–7]. An alternative mechanism
of complex I regulation in cells has been suggested by Papa
and co-workers. These workers suggested that phosphoryla-
tion of the 18 kDa subunit of complex I by a mitochondrial
cAMP-dependent protein kinase [8] modulates the enzymes
activity in cells [9].
Interaction with naturally occurring analogues is one of the
most common mechanisms of enzyme regulation in vivo.
Complex I is, however, almost inert to NADH analogues.
Rotenone and piericidin – classical inhibitors of complex I,
act at or close to the quinone-binding site(s) of the enzyme
[10–12] and suppress quinone reduction at a 1:1 stoichiometry
[10,12]. ATP, ADP, AMP and even NAD+, which appear to
be the closest natural analogues of the substrate, inhibitEuropean Biochemical Societies.
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The only substrate analogue which has relatively high aﬃnity
for the NADH-binding site of complex I is ADP-ribose. It
was shown by Vinogradovs group that ADP-ribose inhibits
NADH oxidation with a Ki value of approximately 30–
40 lM [15]. The aﬃnity of ADP-ribose, however is not suﬃ-
cient to suppress complex I activity in the presence of a high
concentration of NADH moreover, to the best of our knowl-
edge there are no data showing the presence of ADP-ribose
in mitochondria.
In this work, we describe a novel and very potent speciﬁc
competitive inhibitor of complex I. The inhibitor which we
have termed NADH-OH may be structurally similar to
NADH. The high aﬃnity of the inhibitor for the NADH bind-
ing site of complex I also should make it useful for studies of
the mechanism of NADH oxidation by complex I.2. Materials and methods
2.1. Preparations of complex I and other assays
Submitochondrial membranes (SMP) were isolated from rat hearts
as described in [16]. Complex I and FP were the kind gift of Dr. Y.
Hateﬁ (The Scripps Research Institute, La Jolla, USA). Protein con-
centration was determined with the Biuret reagent. All chemicals were
obtained from Sigma Chemical Company.
2.2. Preparation of the inhibitor
NADH (20 mM) was incubated aerobically for 40 days at 4 C in
50 mM KOH and 50% methanol. Incubation of NADH under a nitro-
gen atmosphere suppressed formation of the inhibitor. 40 ml of the
solution was applied to a 5 ml Q-Sepharose column (Amersham Bio-
sciences) equilibrated with 5 mM potassium phosphate (K-Pi) (pH
12). Elution of NADH-OH at pH 12 was with a linear K-Pi gradient
from 5 to 500 mM. The fractions containing NADH-OH were eluted
from the column at approximately 350–400 mM K-Pi and after
authentic NADH. The fractions containing NADH-OH were collected
and rechromatographed under the same conditions as above. All
experiments were conducted at 4 C using a Thermo Finnigan Spectra-
System 2000 HPLC system with a photodiode array detector. Data
were collected from a Thermo Finnigan SpectraSystem UV 6000LP
PDA detector and analyzed with Microsoft Excel.
2.3. Enzyme essays
Enzyme activities were assayed at 25 C in 100 mM K-Pi (pH 7.4),
0.1 mM EDTA, 120 lMNADH (NADH-oxidase) and 2 mM hexaam-
ineruthenium (III) chloride (HAR) and 5 lM rotenone (NADH:HAR
reductase). NADH-oxidase reactions were initiated by addition of the
enzyme preparations and were followed by the decrease of NADH
absorbance at 340 nm (e340 = 6.22 mM1 cm1). Other details of the
assays are indicated in the ﬁgure legends.
2.4. Mass spectrometer conditions
Mass spectrometric measurements were carried out on a Finnigan
LCQ Classic ion trap instrument (ThermoFinnigan, San Jose, CA)
equipped with its standard heated capillary electrospray source. The
source was operated in the negative ion mode. Mass spectra were
recorded in a row scan mode in the mass range from m/z of 400–800.
All mass spectra were obtained by signal averaging for 1 min at a scan
rate of 3 microscans/scan. Solutions of NADH-OH were admitted by
direct infusion with a 100 ll Hamilton gas-tight syringe (Holliston,
MA) at a ﬂow rate of 3 ll/min.3. Results
Incubation of NADH under alkaline conditions as described
in the Materials and Methods results in accumulation of aninhibitor of complex I over time. Incubation of SMP with
NADH exposed to alkaline incubation results in a strong sup-
pression of the NADH-oxidase reaction of complex I. In order
to determine the cause of inhibition the inhibitor was puriﬁed
from non-modiﬁed NADH and other products of NADH deg-
radation using anion exchange HPLC at high pH as described
in Section 2. The fractions containing NADH-OH were re-
chromatographed and analyzed by HPLC (Fig. 1A) and by
electrospray ionization (ESI)-mass spectrometry (see
Fig. 1B). As evident from the data in Fig. 1 the compound
elutes as a single peak (Fig. 1A) and had a molecular mass
of 696 Da (Fig. 1B). Authentic NADH has a molecular mass
of 663.8 Da, so NADH-OH has an additional mass of 32 Da
as compared to authentic NADH.
Using SMP we investigated the kinetics of complex I inhibi-
tion by the inhibitor which we have termed NADH-OH. As
shown in Fig. 2A addition of NADH-OH to the assay results
in rapid (less than a minute) suppression of NADH-oxidase
activity. Preincubation of SMP with the inhibitor, prior to
initiation of the reaction, results in complete inhibition of the
initial rate of NADH oxidation followed by slow activation
of the enzyme (Fig. 2B). Analysis of the ﬁrst order kinetics
of the enzyme activation in a semi-logarithmic plot (the insert)
yielded an activation constant (koﬀ) of 0.1 min
1.
To measure the Ki for the competitive inhibition observed
we used analysis of the dependence of the apparent Km for
NADH on the concentration of NADH-OH. Km values were
estimated from analysis of the dependence of the reaction rate
on NADH concentration in double reciprocal plots. Establish-
ing the equilibrium between the enzyme, NADH, and the
inhibitor is not instantaneous, therefore the rate of the enzy-
matic reaction was measured 5 min after addition of the en-
zyme to the assay containing NADH-OH and NADH, when
steady state conditions have been reached. As seen in Fig. 3
the dependence of the apparent Km on NADH-OH concentra-
tion is linear, indicating a purely competitive character of the
inhibition with respect to NADH. The linear dependence in
the ﬁgure is described by the following equation: Km(app) =
Km(1 + [NADH-OH]/Ki), where [NADH-OH]/Ki corresponds
to a slope of the line on the graph. A Ki value approximately
equal to 108 M for competitive inhibition of the enzyme with
NADH-OH was estimated from this graph. The low Ki value is
consistent with the slow release of the inhibitor as shown in
Fig. 2B. The kinetic data presented strongly suggest that
NADH-OH is a tightly bound competitive inhibitor of com-
plex I.
Being competitive with respect to NADH the inhibitor also
suppresses both NADH-ubiquinone reductase activity and
NADH-artiﬁcial electron acceptor reductase reactions of com-
plex I. The same kinetic patterns of NADH-OH release from
the enzyme as shown in Fig. 2B for NADH-oxidase were
obtained for inhibition of NADH-ferricyanide and NADH-
hexaamineruthenium (III) reductase reactions (not presented).
Identical results were also obtained by measuring the eﬀect of
the inhibitor on NADH-oxidase activity using an oxygraph
(data not shown). We have also demonstrated that the
NADH-OH is characterized by the same aﬃnity for diﬀerent
preparations of NADH-dehydrogenase, i.e., membrane
bound complex I, puriﬁed bovine complex I, or the 3 subunit
ﬂavoprotein fragment (FP). The rates of inhibitor binding
and dissociation from all the above enzyme preparations were
identical.
Fig. 1. HPLC and ESI-MS of NADH-OH. (A). Ion exchange HPLC of NADH-OH. HPLC was carried out as described in Materials and Methods
on a 5 ml Q-Sepharose column (Amersham Biosciences) equilibrated with 5 mM potassium phosphate (K-Pi) (pH 12). Elution of NADH-OH at pH
12 was with a linear (5–500 mM) K-Pi gradient. (B). ESI-MS of NADH-OH in the negative ion mode. Mass spectrometric measurements were
carried out as described in Section 2. A 10 lM solution of NADH-OH was injected into the spectrometer in 5 mM K-Pi (pH 12) by direct infusion
with a 100 ll Hamilton gas-tight syringe at a ﬂow rate of 3 ll/min.
Fig. 2. Kinetics of NADH-OH induced inhibition. (A) Rat heart SMP were assayed in a 1 ml cuvette containing 100 mM K-Pi (pH 7.4), 100 lM
EDTA and 120 lM NADH at 340 nm. (B) SMP were incubated with 1 lM NADH-OH (trace 1) and without the inhibitor (trace 2) for 5 min at
25 C and assayed as above. The inset shows analysis of the time dependence of the reaction rate in a semi-logarithmic plot; the activation constant
(koﬀ) is equal to 0.1 min
1. Addition of 10 ll SMP from a 1 mg/ml suspension and 1 lM NADH-OH are indicated by the arrows.
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bleaching of the FP enzyme. The absorption spectrum of FP is
largely due to the FMN moiety of the enzyme. In addition to
FMN the FP enzyme contains two iron-sulfur centers (centers
N3 and N1a) [17], however, their contribution to the absorp-
tion of the enzyme in the visible spectral region is minor. As
seen in Fig. 4A, addition of NADH-OH to the enzyme results
in about a 10% decrease of the initial absorption of the FP at
445 nm. The eﬀect of NADH-OH on the absorption spectra is
weaker than that induced by NADH (Fig. 4B). The eﬀect of
NADH on the spectrum is mainly due to reduction of the ﬂa-
vin and iron-sulfur clusters of FP. Analysis by EPR shows that
NADH-OH does not cause reduction of the ﬂavin to its radicalform nor any of the iron-sulfur clusters and its presence also
prevents reduction of the iron-sulfur redox centers by NADH
(data not shown). The eﬀect of NADH-OH on the absorption
spectra is thus not associated with reduction of the enzyme and
is one of strongest among those reported for ligands binding to
various ﬂavoproteins [18]. The latter is indicative of close
molecular contact between the ﬂavin and NADH-OH in the
active site of the enzyme.
Formation of NADH-OH from NADH under alkaline con-
ditions and the molecular mass of the compound equal to that
of NADH plus 32 suggest that at high pH two oxygens are
added to NADH by an unknown mechanism to the nicotin-
amide group of the dinucleotide. This suggestion was further
Fig. 3. The dependence of the apparent Km for NADH on the
concentration of NADH-OH. The activity was assayed in 100 mM K-
Pi (pH 7.4), 100 lM EDTA at 340 nm. The dependence of the reaction
rate on NADH concentration at a constant concentration of NADH-
OH (indicated on the axes) was analyzed using double reciprocal
coordinates (Lineweaver–Burk plots) to estimate the apparent Km
values. The value of Km measured in the absence of the inhibitor was
equal to 12 lM. The dependence of apparent Km on NADH-OH
concentration is shown on the ﬁgure. The continuous line is a best ﬁt
for Km(app) = (Km + [NADH-OH]/Ki) equation with the Ki equal to
0.012 lM (1.2 · 108 M).
4864 A.B. Kotlyar et al. / FEBS Letters 579 (2005) 4861–4866supported by data from absorption spectroscopy. As seen in
Fig. 5A at high pH the inhibitor is characterized by an absorp-
tion spectrum with maxima at 260 and 335 nm. The spectrum
changes with pH between 4.5 and 12. Stepwise pH reduction
from 10.5 to 6.5 results in decrease of absorption in the 330–
350 nm region and a peak shift to 300 nm. Authentic NADH
in contrast to NADH-OH shows no diﬀerences in this range.
The pH-dependence of the inhibitors absorption at 340 nm
(around the alkaline maximum) is shown in Fig. 5B. The pK
value estimated for this transition is equal to 8.8.
An extensive search, (over 5 million chemical compounds)
using the ChemNavigator and SciFinder Scholar databases,Fig. 4. Absorption changes induced in FP by NADH-OH and by NADH. Trac
alone. The FP in trace 1 was then mixed with 4 lM NADH-OH (trace 2 o
recorded using an HP diode array spectrophotometer 2 min after the addit
spectrum obtained by subtraction of spectrum1 from 2.looking for NAD+ and NADH derivatives with two additional
oxygen atoms attached to the nicotimamide moiety was under-
taken. No structures ﬁtting this criterion were found in these
databases. The only relevant compounds found were the
following nicotinamide derivatives lacking adenine and ribose:
2,5-dihydroxynicotinamide (Registry Number, 37747-23-2) [19],
4,6-dihydroxynicotinamide (Registry Number, 5466-41-1) and
2,6-dihydroxynicotinamide (Registry Number, 71380-91-1)
[20]. These compounds are characterized by a diﬀerent pK of
the hydroxyl group; the pK values calculated for the 2,4-, 4-
6- and 2,6-derivatives using advanced chemistry development
Software Solaris V4.76 are correspondingly equal to
4.50 ± 1.00, 7.82 ± 0.53, and 8.84 ± 0.40 (see SciFinder). As
the pK of NADH-OH is equal to 8.8 (see Fig. 5B), which cor-
responds very well to the pK of the 2,6-dihydroxynicotinamide
derivative, we speculate that the oxygen atoms attach to the
nicotinamide moiety of the inhibitor at positions 2 and 6 as
shown in Fig. 5C. However, without a deﬁnitive structure of
the inhibitor this conclusion must be taken with caution.
The results presented in Fig. 6 show that NADH-OH is
capable of rapid reduction of electron acceptors, such as ferri-
cyanide and dichlorophenol-indophenol (DCIP), respectively,
indicating the reductive nature of the inhibitor. The reaction
between ferricyanide and the inhibitor (see Fig. 6A) results
in a dramatic decrease of NADH-OH absorption in the 300–
360 nm region. The rate of NADH-OH oxidation by ferricya-
nide is much faster (about two orders of magnitude) than the
rate of NADH oxidation by the dye. This might indicate a
lower midpoint redox potential of NADH-OH compared to
that of NADH or that the product of the one electron oxida-
tion of NADH-OH is more thermodynamically stable com-
pared to that of the NAD radical. The redox reaction
between NADH-OH and DCIP was used (see Fig. 6B) to esti-
mate the extinction coeﬃcient NADH-OH. As seen in the ﬁg-
ure, reduction of DCIP by NADH-OH results in bleaching of
the dye in the 550–560 nm region and a decrease of the inhib-
itors absorption in the 310–380 nm region. The spectra imme-
diately after and 10 min after, mixing the dye and the inhibitore 1 in both panels (A) and (B) shows the spectrum of FP (0.45 mg/ml)
n panel (A)) and 100 lM NADH (trace 2 on panel (B)). Spectra were
ion of NADH-OH or NADH. The insert in panel (B) is a diﬀerence
Fig. 5. pH dependence of absorption spectra of NADH-OH. (A) Spectra of NADH-OH were recorded at diﬀerent pH. (B) Dependence of NADH-OH
absorption at 340 nm as a function of pH. The solid curve is a best ﬁt for a Henderson–Hasselbalch type titration with pK value of 8.8. (C) Tentative
structure for NADH-OH.
Fig. 6. Oxidation of NADH-OH with ferricyanide and DCIP. (A) NADH-OH (20 lM) was mixed with 30 lM potassium ferricyanide in 0.1 M K-Pi,
pH 12 (trace 1) and incubated for 10 min at room temperature (trace 2). (B) NADH-OH (12 lM) in 0.1 M K-Pi, pH 12 was mixed with 12 lMDCIP
and the spectra were recorded immediately (trace 1) and 10 min after (trace 2) mixing of the dye with the inhibitor. The inert is the diﬀerence spectrum
obtained by subtracting the 10 min spectrum (trace 2) from the instantaneous one (trace 1).
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ence spectrum (10 min minus zero min spectrum) is depicted in
the insert to Fig. 6B. There is almost no spectral overlap be-
tween the dye and the inhibitor; the inhibitor does not absorb
in the 550–650 nm region and the diﬀerential absorption of
oxidized and reduced DCIP forms at 335 nm (NADH-OH
maximum) is minor. We estimated the extinction coeﬃcient
of NADH-OH by comparing absorption changes at 600 nm
extinction coeﬃcient of DCIP at alkaline pH at 600 nm is
22000 M1 cm1 [21] and at 335 nm (NADH-OH maximum);
the coeﬃcient at 335 nm is approximately equal to
25000 M1 cm1.4. Discussion
We have discovered a very potent and speciﬁc inhibitor of
complex I which appears to be a derivative of NADH. Theinhibitor is spontaneously formed in alkaline solutions of the
reduced dinucleotide. It is known that at high pH NAD+ rap-
idly decomposes and a number of dinucleotide derivatives are
formed [22–24]. Our data indicate that products obtained by
alkaline treatment of NADH diﬀer from the products of
NAD+ degradation and have much higher inhibition capacity
compared to those obtained by alkaline treatment of NAD+
(data not shown). In contrast to NAD+, NADH is rather sta-
ble at high pH. Thus, prolonged (days) incubation is needed to
produce detectable amounts of the inhibitor. NADH-OH
seems to be the strongest competitive inhibitor of complex I
NADH oxidation reported so far. Its aﬃnity is more than 3
orders of magnitude higher than that of ADP-ribose [15],
and 5 orders higher than that of NAD+ [13]. In addition to
its high aﬃnity the inhibitor is characterized by high speciﬁcity
with respect to complex I. We have examined other
NADH utilizing enzymes such as malate dehydrogenase, lac-
tate dehydrogenase, alcohol dehydrogenase, alternative
4866 A.B. Kotlyar et al. / FEBS Letters 579 (2005) 4861–4866NADH-dehydrogenases of bacterial membranes and have seen
no eﬀect of NADH-OH on the activity of these enzymes (data
not shown). Selective inhibition of complex I may indicate a
diﬀerent organization of the NADH-binding site of complex
I and soluble NADH-dependent deydrogenases.
Based on data of mass and absorption spectroscopy at vari-
ous pH a tentative structure of NADH-OH has been suggested.
In order to conﬁrm the proposed structure and determine the
absolute atomic structure NMR spectroscopy of the compound
will be required. The yield of NADH-OH is rather low and only
sub-milligram quantities of the compound have been produced.
Complete NMR analysis of the compound, however, will
require tens of milligrams of the compound. Improvement in
methodology for production and puriﬁcation of the inhibitor
in order to obtain more material for the structural analysis is
underway. The structural similarity of NADH-OH and NADH
and the high potency and speciﬁcity of the inhibitor with
respect to complex I raise the possibility that it is a natural
derivative of NADH. It may be possible that it could be
produced in mitochondria by enzymatic hydroxylation of the
nicotinamide ring of NADH under certain metabolic condi-
tions. If indeed the inhibitor can be produced in cells this could
provide important insights for understanding the mechanism of
complex I regulation in vivo.
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